June 2, 2009
HemoBioTech to Present
Full Release >>
May 15, 2009
HemoBioTech to Present Blood Substitute Strategy at RENN Capital Investor Conference
Full Release >>
March 12, 2009
HEMOBIOTECH ANNOUNCES ADDITION OF DR. ROSCOE M. MOORE JR. FORMER US ASSISTANT SURGEON GENERAL TO SCIENTIFIC ADVISORY BOARD
Full Release >>
March 10, 2009
HEMOBIOTECH ANNOUNCES DRAMATIC CLEARANCE OF PRIONS WITH THE ORTH TECHNOLOGY
Full Release >>
February 26, 2009
HEMOBIOTECH ANNOUNCES PUBLICATION OF A GUEST EDITORIAL AND TWO REVIEW ARTICLES ON BLOOD SUBSTITUTES BY DR. JAN SIMONI – CO-INVENTOR OF HEMOTECH
Full Release >>
August 7, 2008
HemoBioTech’s CEO, Arthur Bollon, Ph.D., To Present Strategic Vision At The SCIA National Small Cap Syndicate Capital Conference
Full Release >>
June 18, 2008
HemoBioTech Chairman & CEO Arthur Bollon, Ph.D., to Present at the Bio International Convention in San Diego, CA
Full Release >>
May 15, 2008
HEMOBIOTECH LICENSES PATHOGEN (TSE, VIRUSES) CLEARANCE TECHNOLOGY FOR PRODUCTION OF MEDICAL AND COSMETIC PRODUCTS
Full Release >>
May 13, 2008
HemoBioTech Indicates “HEMO TECH” Commercial Development Strategy is Unaffected by Recent FDA/NIH Workshop on Blood Substitutes
Full Release >>
April 17, 2008
HEMOBIOTECH TO PRESENT AT THE EQUITIES 57TH ANNIVERSARY SPRING CONFERENCE
Full Release >>
March 26, 2008
HemoBioTech Featured on Fox News
Full Release >>
February 28, 2008
HemoBioTech’s CEO, Arthur Bollon, PhD, To Present At MedTech Insight In3 Conference
Full Release >>
January 29, 2008
HemoBioTech, Inc. Updates Financial and Media News
Full Release >>
January 16, 2008
HemoBioTech, Inc. Featured in New Scientist Magazine
Full Release >>
December 7, 2007
HemoBioTech Featured In Flaherty Financial News, Inc.
Full Release >>
November 20, 2007
HemoBioTech's Human Blood Substitute, HemoTech, Highlighted in Scientific American Online
Full Release >>
November 2, 2007
HemoBioTech's CEO to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007 in New York City
Full Release >>
October 4, 2007
HemoTech Findings Show Significant Promise For Combating Two Major Complications Involved In Treating Patients With Coronary Artery Disease
Full Release >>
October 1, 2007
HemoBioTech, Inc. Retains the Investor Relations Group, Inc.
Full Release >>
August 13, 2007
Blood substitute update: HemoBioTech Chairman and CEO Dr. Arthur Bollon to give presentation tomorrow, August 14th, about the development of HemoTech, at the ''FFN & WSR Small Cap Conference'' in New York City
Full Release >>
July 31, 2007
HemoBioTech Chairman and CEO, Dr. Arthur Bollon, to Give Update Tomorrow in Dallas on the Company and Development of Its Artificial Blood Product, HemoTech
Full Release >>
July 19, 2007
HemoBioTech Chairman and CEO, Dr. Arthur Bollon, to Give Update Today on the Company and Development of Its Artificial Blood Product, HemoTech
Full Release >>
July 17, 2007
HemoBioTech Takes the Next Step to Facilitate Clinical Study in India of its Human Blood Substitute, HemoTech Promoting Saraswathy Swaminathan to Manager of Foreign Clinical Affairs
Full Release >>
June 21, 2007
HemoBioTech Engages CRO to Facilitate Clinical Study in India of Its Human Blood Substitute, HemoTech
Full Release >>
May 15, 2007
HemoBioTech CEO Dr. Arthur Bollon to Present at the RENN Investor Conference in Dallas on May 18, 2007
Full Release >>
May 9, 2007
HemoBioTech, Inc. Retains Ronald Trahan Associates, Inc.:
Full Release >>
March 20, 2007
HEMOBIOTECH CEO TO PRESENT 16th ANNUAL ROYSTON C. CLOWES MEMORIAL LECTURE SERIES
Full Release >>
Feburary 26, 2007
HEMOBIOTECH TO PRESENT AT 2007 MEDTECH CONFERENCE
Full Release >>
February 1, 2007
HEMOBIOTECH ANNOUNCES EXPANSION OF FACILITIES
Full Release >>
January 31, 2007
HEMOBIOTECH EXPANDS SPONSORED RESEARCH AGREEMENT WITH TEXAS TECH UNIVERSITY
Full Release >>
December 28, 2006
HEMOBIOTECH CHIEF EXECUTIVE OFFICER PROVIDES YEAR END REVIEW AND ADDRESSES GLOBAL STRATEGY
Full Release >>
September 27, 2006
HEMOBIOTECH TO PRESENT AT NanoTX ‘06
Full Release >>
July 17, 2006
HEMOBIOTECH ANNOUNCES CONVERSION OF CLASS A WARRANTS
Full Release >>
June 22, 2006
HEMOBIOTECH INTRODUCES NEW WEBSITE
Full Release >>
June 12, 2006
HEMOBIOTECH ANNOUNCES REDEMPTION OF WARRANTS
Full Release >>
May 18, 2006
HEMOBIOTECH ANNOUNCES FILING OF PATENT APPLICATION FOR BLOOD LOSS TREATMENT
Full Release >>
May 4, 2006
HEMOBIOTECH WILL PRESENT AT RENN INVESTOR CONFERENCE
Full Release >>
February 22, 2006
HEMOBIOTECH TO MAKE PRESENTATION AT MEDTECH CONFERENCE
Full Release >>
February 6, 2006
HEMOBIOTECH ANNOUNCES EXERCISE OF WARRANTS BY RENN CAPITAL
Full Release >>
January 18, 2006
HemoBioTech Signs Third Stage Sponsored Research Agreement with Texas Tech University Health Sciences Center
Full Release >>
December 22, 2005
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on HemoBioTech, Inc.
Full Release >>
December 21, 2005
HEMOBIOTECH, INC. ENGAGES REGULUS FOR FDA SERVICES
Full Release >>
November 11, 2005
HEMOBIOTECH, INC. COMMON STOCK QUOTED on OTCBB
Full Release >>
August 17, 2005
HEMOBIOTECH ANNOUNCES CONVERSION OF $750,000 AGGREGATE PRINCIPAL AMOUNT OF CONVERTIBLE PROMISSORY NOTES
Full Release >>